113 related articles for article (PubMed ID: 15467580)
1. The impact of protease inhibitors on maternal serum screening analyte levels in pregnant women who are HIV positive.
Einstein FH; Wright RL; Trentacoste S; Gross S; Merkatz IR; Bernstein PS
Am J Obstet Gynecol; 2004 Sep; 191(3):1004-8. PubMed ID: 15467580
[TBL] [Abstract][Full Text] [Related]
2. Maternal biochemical serum screening for Down syndrome in pregnancy with human immunodeficiency virus infection.
Le Meaux JP; Tsatsaris V; Schmitz T; Fulla Y; Launay O; Goffinet F; Azria E
Obstet Gynecol; 2008 Aug; 112(2 Pt 1):223-30. PubMed ID: 18669715
[TBL] [Abstract][Full Text] [Related]
3. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
4. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women.
Sritippayawan S; Vachirasrisoontra C
J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246
[TBL] [Abstract][Full Text] [Related]
5. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
6. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ;
AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463
[TBL] [Abstract][Full Text] [Related]
7. Maternal serum alpha-fetoprotein and human chorionic gonadotropin levels in women with human immunodeficiency virus.
Gross S; Castillo W; Crane M; Espinosa B; Carter S; DeVeaux R; Salafia C
Am J Obstet Gynecol; 2003 Apr; 188(4):1052-6. PubMed ID: 12712109
[TBL] [Abstract][Full Text] [Related]
8. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Rice JD; McIntosh SF; Halstead AC
Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
[TBL] [Abstract][Full Text] [Related]
9. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
Huttly W; Rudnicka A; Wald NJ
Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275
[TBL] [Abstract][Full Text] [Related]
10. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
11. Multiple-marker screening in human immunodeficiency virus-positive pregnant women: Screen positivity rates with the triple and quad screens.
Yudin MH; Prosen TL; Landers DV
Am J Obstet Gynecol; 2003 Oct; 189(4):973-6. PubMed ID: 14586337
[TBL] [Abstract][Full Text] [Related]
12. Reliability of second trimester triple screening for Down syndrome in rhesus-negative women.
Muhcu M; Mungen E; Dundar O; Bodur S; Tutuncu L; Atay V; Ozcan O; Yergok YZ
J Perinatol; 2007 May; 27(5):268-71. PubMed ID: 17363912
[TBL] [Abstract][Full Text] [Related]
13. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
[TBL] [Abstract][Full Text] [Related]
14. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
Sancken U; Bartels I
Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
[TBL] [Abstract][Full Text] [Related]
15. The relationship between maternal serum alpha-fetoprotein and maternal haemoglobin.
Bartha JL; Omar KM; Soothill PW
Prenat Diagn; 2004 Aug; 24(8):609-12. PubMed ID: 15305347
[TBL] [Abstract][Full Text] [Related]
16. Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies.
Huang T; Boucher K; Summers AM
Prenat Diagn; 2007 Dec; 27(12):1138-42. PubMed ID: 17960787
[TBL] [Abstract][Full Text] [Related]
17. Low estriol levels in the maternal triple-marker screen as a predictor of isolated adrenocorticotropic hormone deficiency caused by a new mutation in the TPIT gene.
Weintrob N; Drouin J; Vallette-Kasic S; Taub E; Marom D; Lebenthal Y; Klinger G; Bron-Harlev E; Shohat M
Pediatrics; 2006 Feb; 117(2):e322-7. PubMed ID: 16390921
[TBL] [Abstract][Full Text] [Related]
18. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
[TBL] [Abstract][Full Text] [Related]
19. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
20. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
Hu YL;
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
